Establishment Labs (ESTA) Competitors $37.70 -0.55 (-1.44%) Closing price 08/19/2025 04:00 PM EasternExtended Trading$38.00 +0.30 (+0.80%) As of 07:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. TMDX, NVST, LIVN, WRBY, INSP, PRCT, LMAT, EYE, AORT, and LQDAShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), National Vision (EYE), Artivion (AORT), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Its Competitors TransMedics Group Envista LivaNova Warby Parker Inspire Medical Systems PROCEPT BioRobotics LeMaitre Vascular National Vision Artivion Liquidia Technologies Establishment Labs (NASDAQ:ESTA) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment. Which has more risk and volatility, ESTA or TMDX? Establishment Labs has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Which has higher earnings and valuation, ESTA or TMDX? TransMedics Group has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$177.42M6.16-$84.60M-$3.05-12.36TransMedics Group$531.29M7.87$35.46M$1.9363.56 Do institutionals & insiders have more ownership in ESTA or TMDX? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 7.0% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is ESTA or TMDX more profitable? TransMedics Group has a net margin of 13.49% compared to Establishment Labs' net margin of -49.89%. TransMedics Group's return on equity of 28.02% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-49.89% -224.34% -25.53% TransMedics Group 13.49%28.02%8.64% Does the media refer more to ESTA or TMDX? In the previous week, Establishment Labs and Establishment Labs both had 6 articles in the media. TransMedics Group's average media sentiment score of 1.13 beat Establishment Labs' score of 0.79 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ESTA or TMDX? Establishment Labs currently has a consensus target price of $55.80, indicating a potential upside of 48.01%. TransMedics Group has a consensus target price of $123.00, indicating a potential upside of 0.26%. Given Establishment Labs' stronger consensus rating and higher probable upside, research analysts clearly believe Establishment Labs is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 SummaryTransMedics Group beats Establishment Labs on 13 of the 16 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.11B$7.66B$5.73B$9.79BDividend YieldN/A2.76%4.54%4.09%P/E Ratio-12.3674.7930.7225.12Price / Sales6.1631.41418.7096.88Price / CashN/A23.8337.3459.16Price / Book47.7216.418.896.24Net Income-$84.60M$243.33M$3.26B$265.56M7 Day Performance-1.67%-0.23%-0.38%-1.76%1 Month Performance-9.31%2.00%3.54%0.61%1 Year Performance-14.43%12.93%28.53%20.84% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.2728 of 5 stars$37.70-1.4%$55.80+48.0%-13.9%$1.11B$177.42M-12.361,018TMDXTransMedics Group2.7595 of 5 stars$127.26+11.1%$123.00-3.3%-26.6%$3.90B$441.54M65.94210Positive NewsNVSTEnvista3.683 of 5 stars$20.19-0.3%$20.92+3.7%+13.1%$3.36B$2.51B63.0812,300LIVNLivaNova2.5897 of 5 stars$49.56+1.5%$59.29+19.6%+16.3%$2.67B$1.25B-12.742,900Positive NewsWRBYWarby Parker2.3166 of 5 stars$23.25-0.4%$24.06+3.5%+84.8%$2.44B$771.32M-332.023,780INSPInspire Medical Systems4.9309 of 5 stars$79.62+0.6%$173.31+117.7%-53.6%$2.34B$802.80M46.021,246Positive NewsBuyback AnnouncementShort Interest ↓PRCTPROCEPT BioRobotics3.5031 of 5 stars$38.77+0.9%$74.88+93.1%-39.4%$2.14B$224.50M-25.01430LMATLeMaitre Vascular2.0863 of 5 stars$92.62+0.4%$98.00+5.8%+11.5%$2.09B$219.86M44.96490EYENational Vision2.6246 of 5 stars$22.77+0.6%$24.73+8.6%+118.8%$1.79B$1.82B-126.5213,411Positive NewsAORTArtivion3.3374 of 5 stars$43.05+5.1%$40.00-7.1%+66.7%$1.75B$388.54M-102.511,600Analyst DowngradeInsider TradeHigh Trading VolumeLQDALiquidia Technologies3.4885 of 5 stars$21.20+3.7%$26.89+26.8%+176.9%$1.75B$14M-13.4250 Related Companies and Tools Related Companies TransMedics Group Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives LeMaitre Vascular Alternatives National Vision Alternatives Artivion Alternatives Liquidia Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSeptember 16 Could Crush Your Tech StocksMillions of investors are piled into the same megacap tech stocks—Nvidia, Microsoft, Amazon, Tesla. But Wall S...InvestorPlace | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access